U.S. Government Invests a Billion Dollars in new Funding for Alzheimer’s Breakthrough Technologies
LOS ANGELES CALIFORNIA, November 15, 2022 (GLOBE NEWSWIRE) — MetAlert, Inc. (OTC: MLRT), a pioneer in the field of wearable GPS human and asset tracking and remote patient monitoring, announced Canadian distributor Red Dot Alerts has launched the new award-winning 4G GPS SmartSole, a wearable medical monitoring device integrated into an orthotic insole allowing discreet tracking and remote monitoring of Alzheimer’s, dementia, and autism sufferers.
“We are thrilled to offer the GPS SmartSole to Canadians,” stated Roxanne Ayotte, Director of Business Operations at Red Dot Alerts. “This innovative insole could be lifesaving for anyone who tends to wander, like seniors with dementia and children with autism. With a click of the app, caregivers can rest easy knowing where their loved ones are. It’s truly a game-changer.”
The product launch is supported by a marketing and advertising campaign, including radio ads, magazine ads and mailers to medical clinics, hospitals, pharmacies, and senior residence facilities across Canada. Some of the ads were placed on BOOM Radio, CARP (Canadian Association for Retired People), Bruyère Foundation and Magazine 55+ just to name a few. The advertising campaign will continue into spring 2023 to coincide with Canada’s Fall Prevention Month in November and Alzheimer’s Awareness Month in January.
In the U.S., the White House has proclaimed November as National Alzheimer’s Awareness Month. MetAlert is supporting the caregivers and family members of millions of people who have been diagnosed with this dreadful disease, and to the administration which has launched the Advanced Research Projects Agency for Health (ARPA-H) at the National Institutes of Health, which is investing a billion dollars in cutting-edge research for Alzheimer’s. Modelled on the Pentagon program that brought game-changing technologies like the internet and GPS, the key technologies in MetAlert’s GPS SmartSoles, ARPA-H will support bold ideas to pursue and drive new biomedical breakthroughs. At the same time, the Department of Health and Human Services is investing in research and technology that can keep Alzheimer’s patients living longer in their own homes; training caregivers to support them; and educating Americans about early warning signs of Alzheimer’s, dementia risks, and general brain health, all of which MetAlert provides products and solutions for.
Alzheimer’s has become a global epidemic amongst people over 65, robbing them of their memories, thoughts, identity and even their ability to go for a leisurely walk. Straining family members and caregivers who stand by their side throughout the progression of this disease, both financially and emotionally.
“Insurance or government financial assistance is a key component in helping families address the costs associated with caring for someone with Alzheimer’s or dementia. Qualifying GPS SmartSole customers can receive assistance from Medicaid programs, using our National Provider Identifier (NPI): 1447709290. And similar reimbursement programs have been initiated for the GPS SmartSole in other countries such as Canada, the U.K. and Norway, so we are very excited to hear about additional funding becoming available through this new ARPA-H program the administration has launched with a billion-dollar commitment,” stated MetAlert CEO Patrick Bertagna
PubCoInsights recently wrote – With MetAlert’s GPS SmartSole, caregivers can have peace of mind knowing their loved one is safe at all times. SmartSole uses patented technology to provide real-time location data for loved ones who wander off.
About Red Dot Alerts
Red Dot Alerts is a Canadian owned and operated company with a 30-year history of caring for clients. Its purpose is to help people continue to live their lives independently and safely. Created by specialists in elderly care, Red Dot Alerts is Canada’s only personal alert solution company offering a range of custom products including the GPS SmartSole®. Learn more at RedDotAlerts.ca.
MetAlert (OTC: MLRT) and its subsidiaries occupy a commanding position in the design, development, manufacturing, distribution, sales, and licensing of GPS wearable technology, asset recovery services, wandering assistive technology, and health data collection and monitoring. The Company delivers comprehensive global solutions encompassing logistics, hardware, software, and connectivity.
Notable achievements include GunAlert the world’s first all in one firearm safety solution gun lock with patented motion sensor and GPS theft recovery. And the groundbreaking GPS SmartSole®, a fusion of Dr. Scholl’s comfort with LoJack’s tracking prowess. It stands as the world’s inaugural invisible wearable tracking device, designed for individuals susceptible to wandering due to Alzheimer’s, dementia, autism, and traumatic brain injury. MetAlert’s subscription-based model thrives on technology innovation fortified by intellectual property safeguards. The company boasts international distribution channels serving customers across 40 countries, alongside its role as a U.S. Military Government contractor. In addition to public health entities, MetAlert caters to municipalities, emergency and law enforcement agencies, private educational institutions, assisted living facilities, NGOs, senior care residences, consumers, and small enterprises.
General information, investor relations, wholesale licensing, consumer purchase:
213.489.3019 | Info@MetAlert.com | IR@MetAlert.com | Contact Us
MetAlert.com | Mygunalert.com | Track My Workforce | GPS SmartSole.com
MetAlert United Kingdom– In the UK, MetAlert operates from its London office.
Please contact: Nelson Skip Riddle | Email: NSRiddle@MetAlert.com | Tel: +44 7785 364100
Level 2 Security (Wholly owned subsidiary) Email: contactus@level2sec.com | www.mygunalert.com | www.ifitmoves.com
Forward Looking Statements
This news release contains forward-looking statements. The terms and phrases “expects,” “would,” “will,” “believes,” and similar terms and phrases are intended to identify these forward-looking statements. Forward-looking statements are based on estimates and assumptions made by MetAlert considering its experience and perception of current conditions and expected future developments, as well as other factors that MetAlert believes are appropriate in the circumstances. Many factors could cause MetAlert’s actual results, performance, or achievements to differ materially from those expressed or implied by the forward-looking statements. Certain risk factors that may cause actual results to differ are outlined in MetAlert’s Annual Report on Form 10-K filed with the U.S. Securities and Exchange Commission (which may be obtained on the SEC Website). These factors should be considered carefully, and readers should not rely on MetAlert’s forward-looking statements. MetAlert has no intention and undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required.
Disclaimer: MetAlert does not warrant or represent that the unauthorized use of materials drawn from this document’s content will not infringe the rights of third parties who are not owned or affiliated by MetAlert. Further, MetAlert cannot be held responsible or liable for the unauthorized use of this document’s content by third parties unknown to the company.